Half Year 2020 Futura Medical PLC Earnings Call Transcript
Good morning, everybody, and welcome to Futura's webcast for the interim results for 6 months ending the 30th of June 2020. I am James Barder, the Chief Executive of the company, and I'm pleased to be joined by both Ken James, who is Executive Head of R&D; and Angela Hildreth, who is the Finance Director and Chief Operating Officer.
A corporate overview of the company. We're obviously listed on AIM, and we describe ourselves as a virtual organization. We employ 13 staff. We have a low overhead base, and we have a significant outsourced infrastructure with over 30 consultants.
Our real core skill set is what we describe as applying skin science to deliver novel topical clinically proven products. And our main sort of core asset we describe as DermaSys. Again, we're looking to add licensed products and as such, it's all around about us being able to deliver clinically proven innovation in our 2 real key areas of expertise in sexual health and pain management.
Today, we're going to be talking about 3
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
